UC Irvine researchers develop rapid antibody generation technology that could target COVID-19

When the coronavirus pandemic hit, a team led by UC Irvine and Harvard Medical School researchers started discussing how to apply their ongoing work to the current climate. … “We decided to apply it to some coronavirus targets, the S-protein,” said Chang Liu, UCI assistant professor of biomedical engineering. “As we were furthering our development of the technology, it’s started working very well on these COVID targets.”